Wells Fargo & Company Organon & Co. Put Options Transaction History
Wells Fargo & Company
- $407 Billion
- Q2 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding OGN
# of Institutions
775Shares Held
190MCall Options Held
1.59MPut Options Held
931K-
Black Rock Inc. New York, NY32.6MShares$525 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA30.2MShares$487 Million0.01% of portfolio
-
Massachusetts Financial Services CO Boston, MA10.1MShares$163 Million0.07% of portfolio
-
State Street Corp Boston, MA9.01MShares$145 Million0.01% of portfolio
-
Nordea Investment Management Ab Stockholm, V76.74MShares$109 Million0.15% of portfolio
About Organon & Co.
- Ticker OGN
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 254,330,000
- Market Cap $4.1B
- Description
- Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...